This event is now SOLD OUT! Due to limited space, walk-ins will not be available.
NEDO and Silicon Valley Forum welcome you to our 8th Japanese Pitch Night, our longest-running international series! Meet an amazing new group of technology startups from Japan, who will present their companies onstage for the first time ever in Silicon Valley. In addition to the pitching, this event will also feature a panel discussion on the latest trends in health tech investment trends in Japan and the US.
Tickets are free and this event
will reach HAS reached capacity – hope you got your ticket! #JapangoesSVSpeakersAgenda6:00 – 6:30 pm Registration and networking
6:30 – 6:40 pm Welcome Remarks: Silicon Valley Forum and NEDO Silicon Valley
6:40 – 6:45 pm Panel Introduction
6:45 – 7:30 pm Panel Discussion: Current Trends in HealthTech – Japan and the US
7:30 – 8:20 pm Pitch Session (5m pitch, 3m Q&A, 2m feedback)
8:20 – 9:00 pm Final remarks, Networking, and RefreshmentsStartups
XELA Robotics is the only producer and seller of 3-axis tactile skin sensor patches for use in robotic applications such as grippers and robot arms. Our products can provide solutions for robots in packaging & warehousing, gaming devices, assembly, food, surgical and service robots. The company was founded in August 2018 and has achieved revenues of 94.000$ in its first operating year. Our team consists out of 9 people with a collective experience of 73 years in tactile sensing. XELA Robotics – provides the human sense of touch to robots. BionicM Inc. was founded in 2018 aiming to provide high-functional robotic prosthesis based on the humanoid robotics technology developed by Dr. Sun Xiaojun, Founder and CEO of BionicM, and amputee. The technology is unique in motion assistance and natural movement which help amputees’ mobility. BionicM is trying to solve the both problems of non-powered prosthesis and powered prosthesis by utilizing their technology to improve the QOL of +10 million of amputees in the world.We introduced a new protein synthesis technology that is 100x more cost effective, 24x smaller and 30x faster than current GMO solutions, a combined $146B market. We are expanding the business from research to large scale protein production for medical and food additive protein market. With this, we are cutting down medical bills and even reducing health disparities among the world as well as contributing to food security via alternative meat and cultured meat. Braizon Therapeutics, Inc. was founded in 2015 with a novel drug delivery solution for treatment of diseases in the brain. A natural protective barrier massively limits drug access to brain tissue from the blood. This has restricted pharma industry efforts to develop more effective treatments for diseases with pressing needs such as; Alzheimer’s, ALS, depression, and chronic pain. Braizon’s patented technology can be applied to efficiently deliver a wide range of drug types across this barrier. With locations in Japan (Tokyo) and the U.S.A. (Boston), Braizon is utilizing our existing capital ($7M), and partnerships in biotech and pharma to bring this solution to patients worldwide as rapidly as possible. Founded in 2017, Precision, Inc, specializes in creating clinical decision support. Our product provides fast, easy, and accurate answers at point of care, with input from 2000 prestigious medical doctors in Japan. Our goal is to create a “content technology merged solution” to improve the quality of care, reducing medical errors. We also are looking for opportunities to apply our solution in the U.S.
In Partnership With